The downregulation of HDAC6 was shown to inhibit the proliferation and migration of glioblastoma cell lines [9], and ACY-1215 (Ricolinostat, a specific HDAC6 inhibitor) inhibits glioblastoma growth [10]. Here, HDAC6 is linked to glioblastoma.